Ibrutinib
Ibrutinib (trade names include: Ibrunat, Imbruvica) is used for the treatment of B cell cancers.
Indications include:
mantle cell lymphoma
chronic lymphocytic leukemia
Waldenstrom's macroglobulinemia
Conseils d’utilisation
Follow the directions for using this medicine provided by your doctor. Take Ibrutinib exactly as directed.
Composants
Active ingredient: ibrutinib.